NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

In 8k dated 1 Sep, Linda says

"The phased buildout of our Sawston, UK facility and now our acquisition of Flaskworks are major building blocks towards achieving these goals. These steps, along with others in process, have been years in the making to reach fruition at the same time as we are reaching the results of our Phase 3 clinical trial of DCVax-L for Glioblastoma."

Can that statement serve as an update or indication maybe what we expect the next is not DL but Topline data?

plus, the company had talked about what venue and time the company will determine to present findings of the trial in consultation with PI and other experts after the company is unblinded.

Now it seems LL and Bosch will be presenting on 20 Nov, preceded by LP's presence/speaking on 12 Sep.

Is the above also indication that the data has been locked pending public reporting?

I would say either way, ie, the company will report DL or the company will directly report Topline data bypassing DL announcement, is likely.

Honestly, I like this ambiguity since I plan to hold the vast majority of my shares for a long term, and because it irritates traders and shorts.